Search research articles
Contact Us
Filters
Showing results (161-170 of 166) with videos related to
Page
of 17
Sort By:
You have reached the last page of results.
This site can display upto 166 results.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
July 21, 2005
Primary chemotherapy with gemcitabine as prolonged infusion, non-pegylated liposomal doxorubicin and docetaxel in patients with early breast cancer: final results of a phase II trial
P Schmid, J Krocker, C Jehn, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
January 23, 2008
A phase I/II study of bortezomib and capecitabine in patients with metastatic breast cancer previously treated with taxanes and/or anthracyclines
P Schmid, D Kühnhardt, P Kiewe, et al.
Cancer Research
|
October 15, 1996
Clinical experiences with magnetic drug targeting: a phase I study with 4'-epidoxorubicin in 14 patients with advanced solid tumors
A S Lübbe, C Bergemann, H Riess, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 28, 2004
High-dose chemotherapy with autologous hematopoietic stem-cell support compared with standard-dose chemotherapy in breast cancer patients with 10 or more positive lymph nodes: first results of a randomized trial
A R Zander, N Kröger, C Schmoor, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
July 13, 2006
Second consensus on medical treatment of metastatic breast cancer
S Beslija, J Bonneterre, H Burstein, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
July 18, 2009
Third consensus on medical treatment of metastatic breast cancer
S Beslija, J Bonneterre, H J Burstein, et al.
Page
of 17
Search research articles
Search
Showing results (161-170 of 166) with videos related to
Sort By:
Page
of 17
You have reached the last page of results.
This site can display upto 166 results.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
July 21, 2005
Primary chemotherapy with gemcitabine as prolonged infusion, non-pegylated liposomal doxorubicin and docetaxel in patients with early breast cancer: final results of a phase II trial
P Schmid, J Krocker, C Jehn, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
January 23, 2008
A phase I/II study of bortezomib and capecitabine in patients with metastatic breast cancer previously treated with taxanes and/or anthracyclines
P Schmid, D Kühnhardt, P Kiewe, et al.
Cancer Research
|
October 15, 1996
Clinical experiences with magnetic drug targeting: a phase I study with 4'-epidoxorubicin in 14 patients with advanced solid tumors
A S Lübbe, C Bergemann, H Riess, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 28, 2004
High-dose chemotherapy with autologous hematopoietic stem-cell support compared with standard-dose chemotherapy in breast cancer patients with 10 or more positive lymph nodes: first results of a randomized trial
A R Zander, N Kröger, C Schmoor, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
July 13, 2006
Second consensus on medical treatment of metastatic breast cancer
S Beslija, J Bonneterre, H Burstein, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
July 18, 2009
Third consensus on medical treatment of metastatic breast cancer
S Beslija, J Bonneterre, H J Burstein, et al.
Page
of 17